Ann: Final Data Readout for Orthocells Nerve Reconstruction Study, page-40

I just believe the connections and knowledge he has would be hard to replace. I think he would be good behind the scenes. Get a good proactive MD to dtive the products into the market place. Without Paul there wouldn't be an orthocell and they are progressing. Ive been on companies with much worse and the reverse, they got so far in front of themselves tripped up. Over the next couple of years progress to date means pieces of the jigsaw puzzle could quickly fall in to place and we could progress quite fast.

I am also unsure what it means with them presenting ati results at the TOBI conference, does this mean jnj are not interested? Is ati dead in the water?